Publication | Closed Access

Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II

BiochemistryCatalytic InhibitorTopoisomerase IiMedicineMechanism Of ActionAnti-cancer AgentPharmacologyBisdioxopiperazine DexrazoxaneDrug DiscoveryOvarian CancerDrug Resistance